Resveratrol: a supplementation for men or for mice?

Area of Science:

• Biochemistry
• Pharmacology
• Gerontology

Background:

• Resveratrol, a plant-derived polyphenol, has garnered significant research interest due to reported metabolic and lifespan-extending benefits in various organisms.
• In vitro and animal studies indicate resveratrol interacts with molecular targets like sirtuins, NAD+-dependent deacetylases, suggesting potential therapeutic applications.

Discussion:

• Human clinical trials on resveratrol supplementation have produced inconsistent outcomes.
• Discrepancies in human study results may stem from variations in patient characteristics, dosage, and treatment duration.
• Key unresolved questions include optimal dosing, treatment duration, resveratrol bioavailability, and the impact of food matrices on bioactivity.

Key Insights:

• While animal and in vitro studies are promising, robust human evidence supporting resveratrol's benefits is currently lacking.
• The bioavailability and efficacy of resveratrol in humans remain areas requiring extensive investigation.
• Variability in study design significantly impacts the interpretation of resveratrol's effects in human populations.

Outlook:

• Further well-controlled human clinical trials are essential to elucidate resveratrol's true efficacy and safety.
• Research should focus on optimizing resveratrol delivery, dosage, and understanding its interaction with the human biological system.
• Clarifying the role of the food matrix in enhancing resveratrol's bioactivity is crucial for future supplement development.